CURB-65 Score for Pneumonia Severity
The CURB-65 score assesses the severity of community-acquired pneumonia and estimates 30-day mortality risk. Use it to guide decisions about outpatient versus inpatient treatment.
Understanding Pneumonia Severity Assessment
Community-acquired pneumonia ranges from mild illness treatable at home to life-threatening septic shock requiring ICU care. Accurately assessing severity guides antibiotic choice, monitoring intensity, and admission decisions. The CURB-65 score provides a standardized, evidence-based approach to stratify risk.
Each of the five criteria predicts worse outcomes. Confusion indicates severe illness affecting mentation, possibly from hypoxia or sepsis. Elevated urea (blood urea nitrogen) suggests dehydration or renal hypoperfusion. Respiratory rate of 30 or more signals respiratory distress. Low blood pressure (systolic <90 or diastolic β€60 mmHg) indicates shock. Age 65 or older independently increases mortality due to reduced physiologic reserve and comorbidities.
The score assigns one point per criterion and sums them. Scores range from 0 (very low risk) to 5 (very high risk). This simple calculation can be done at the bedside without complex formulas or computer tools, making CURB-65 practical in busy emergency departments and outpatient clinics.
Applying CURB-65 to Clinical Decisions
Low-risk patients (score 0-1) have less than 3% 30-day mortality and can often be treated as outpatients if they have no other complicating factors (like inability to take oral medications, homelessness, or severe comorbidities). Oral antibiotics, hydration, and follow-up within 48 hours usually suffice.
Moderate-risk patients (score 2) have around 9% mortality. They fall into a gray zone where some can be managed at home with close follow-up, while others benefit from brief hospitalization or observation unit care. Consider the patient's ability to comply with treatment, access to follow-up, and comorbidities like diabetes or heart failure when making this decision.
High-risk patients (score 3) have 15-40% mortality and should be hospitalized. These patients need intravenous antibiotics, oxygen therapy, and monitoring for deterioration. Very high-risk patients (score 4-5) often require ICU admission for potential mechanical ventilation or vasopressor support. Early identification of severe pneumonia improves outcomes by ensuring timely, aggressive treatment.
Limitations and Complementary Tools
CURB-65 performs well for most pneumonia cases but has limitations. It does not account for all comorbidities like immunosuppression, chronic lung disease, or heart failure. Patients with these conditions may need hospitalization even with low scores. Social factors like homelessness or inability to take oral medications also influence disposition and are not captured by the score.
The Pneumonia Severity Index (PSI) is an alternative that includes more variables and categorizes patients into five risk classes. It is more complex but slightly more accurate. Some clinicians use both: CURB-65 for quick bedside assessment and PSI for detailed risk stratification.
Clinical judgment remains paramount. CURB-65 is a guide, not a mandate. A patient with score 1 who appears severely ill, has low oxygen saturation, or cannot take oral antibiotics should be admitted. Conversely, a patient with score 2 who feels well, tolerates oral intake, and has good social support may be managed at home with close outpatient follow-up. Use the score to inform decisions, but always incorporate the full clinical picture.
Frequently Asked Questions
What does CURB-65 stand for?
CURB-65 is an acronym: Confusion, Urea (elevated), Respiratory rate (β₯30), Blood pressure (low), and age 65 or older. Each factor present adds one point to the score.
How does CURB-65 predict mortality?
The score correlates with 30-day mortality from pneumonia. Score 0-1 has <3% mortality, score 2 has ~9%, score 3 has 15-40%, and scores 4-5 have >40% mortality. It helps identify patients who need intensive monitoring.
Can I use CURB-65 for hospital-acquired pneumonia?
CURB-65 was developed and validated for community-acquired pneumonia. It is less accurate for hospital-acquired or ventilator-associated pneumonia, which have different microbiology and risk factors.
What is the difference between CURB-65 and CRB-65?
CRB-65 omits the urea criterion, making it easier to use in settings where lab results are not immediately available. It is slightly less accurate but useful in outpatient or urgent care settings.
Should all CURB-65 score 2 patients be admitted?
Not necessarily. Score 2 represents moderate risk. Many can be managed as outpatients with close follow-up or in observation units. Consider comorbidities, social support, and ability to take oral antibiotics when deciding.